| 1897- | dietMet, | Methionine metabolism in health and cancer: a nexus of diet and precision medicine |
| - | Review, | Var, | NA |
| 1896- | dietMet, | Dietary methionine links nutrition and metabolism to the efficacy of cancer therapies |
| - | in-vivo, | CRC, | NA |
| 1895- | dietMet, | Altering Diet Enhances Response to Cancer Treatments in Mice |
| - | Review, | Var, | NA |
| 1894- | dietMet, | Long term methionine restriction: Influence on gut microbiome and metabolic characteristics |
| - | in-vivo, | Nor, | NA |
| 1893- | dietMet, | Clinical Studies of Methionine-Restricted Diets for Cancer Patients |
| - | Review, | Var, | NA |
| 5188- | dietMet, | Dietary methionine links nutrition and metabolism to the efficacy of cancer therapies |
| - | in-vivo, | Var, | NA |
| 5193- | dietMet, | Rad, | A Phase I Trial of a Methionine Restricted Diet with Concurrent Radiation Therapy |
| - | Trial, | Var, | NA |
| 5192- | dietMet, | Intermittent methionine restriction reduces IGF‐1 levels and produces similar healthspan benefits to continuous methionine restriction |
| 5191- | dietMet, | Intermittent dietary methionine deprivation facilitates tumoral ferroptosis and synergizes with checkpoint blockade |
| - | in-vitro, | Colon, | HT29 |
| 5190- | dietMet, | Methionine restriction activates the integrated stress response in triple-negative breast cancer cells by a GCN2- and PERK-independent mechanism |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MDA-MB-468 |
| 5189- | dietMet, | Mechanism of Activation of Mechanistic Target of Rapamycin Complex 1 by Methionine |
| - | Review, | Var, | NA |
| 2161- | dietP, | Plant-Based Diets and Cancer Prognosis: a Review of Recent Research |
| - | Review, | NA, | NA |
| 2165- | dietP, | SFN, | Broccoli sprout supplementation in patients with advanced pancreatic cancer is difficult despite positive effects—results from the POUDER pilot study |
| - | Trial, | PC, | NA |
| 2163- | dietP, | SFN, | Intake of Cruciferous Vegetables Modifies Bladder Cancer Survival |
| - | Human, | Bladder, | NA |
| 2162- | dietP, | Effect of low-fat diet on breast cancer survival: a meta-analysis |
| - | Analysis, | BC, | NA |
| 2160- | dietP, | Dietary proteins and protein sources and risk of death: the Kuopio Ischaemic Heart Disease Risk Factor Study |
| - | Trial, | Heart, | NA |
| 2159- | dietP, | Postdiagnostic Fruit and Vegetable Consumption and Breast Cancer Survival: Prospective Analyses in the Nurses' Health Studies |
| - | Human, | BC, | NA |
| 2158- | dietP, | Association of Animal and Plant Protein Intake With All-Cause and Cause-Specific Mortality in a Japanese Cohort |
| - | Human, | Nor, | NA |
| 2157- | dietP, | Plant-Based Diets and Disease Progression in Men With Prostate Cancer |
| - | Study, | Pca, | NA |
| 2156- | dietP, | Phytochemical-rich vegetable and fruit juice alleviates oral mucositis during concurrent chemoradiotherapy in patients with locally advanced head and neck cancer |
| - | Human, | HNSCC, | NA |
| 2155- | dietP, | Transepithelial Anti-Neuroblastoma Response to Kale among Four Vegetable Juices Using In Vitro Model Co-Culture System |
| - | in-vivo, | neuroblastoma, | Caco-2 | - | NA, | NA, | SH-SY5Y |
| - | Trial, | Colon, | NA |
| 5065- | dietSTF, | dietFMD, | Nutrition, GH/IGF-I Signaling, and Cancer |
| - | Review, | Var, | NA |
| 5066- | dietSTF, | Intermittent and Periodic Fasting, Hormones, and Cancer Prevention |
| - | Review, | Var, | NA |
| 5068- | dietSTF, | mTOR-autophagy axis regulation by intermittent fasting promotes skeletal muscle growth and differentiation |
| - | in-vivo, | Nor, | NA |
| 5069- | dietSTF, | The Role of Intermittent Fasting in the Activation of Autophagy Processes in the Context of Cancer Diseases |
| - | Review, | Var, | NA |
| 5070- | dietSTF, | A review of fasting effects on the response of cancer to chemotherapy |
| - | Review, | Var, | NA |
| 5071- | dietSTF, | Unraveling the impact of intermittent fasting in cancer prevention, mitigation, and treatment: A narrative review |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 4180- | dietSTF, | Brain-derived neurotrophic factor, but not body weight, correlated with a reduction in depression scale scores in men with metabolic syndrome: a prospective weight-reduction study |
| - | Human, | Obesity, | NA |
| 4159- | dietSTF, | 2DG, | CRMs, | Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular and molecular mechanisms |
| - | Review, | AD, | NA |
| 3708- | dietSTF, | Fasting as a Therapy in Neurological Disease |
| 3707- | dietSTF, | Intermittent fasting protects against the deterioration of cognitive function, energy metabolism and dyslipidemia in Alzheimer’s disease-induced estrogen deficient rats |
| - | in-vivo, | AD, | NA |
| 3709- | dietSTF, | Intermittent Fasting Protects against Alzheimer’s Disease Possible through Restoring Aquaporin-4 Polarity |
| - | in-vitro, | AD, | NA |
| 1626- | dietSTF, | dietFMD, | When less may be more: calorie restriction and response to cancer therapy |
| - | Review, | Var, | NA |
| 4984- | Dipy, | ATV, | Immediate Utility of Two Approved Agents to Target Both the Metabolic Mevalonate Pathway and Its Restorative Feedback Loop |
| - | in-vitro, | AML, | NA |
| 4990- | Dipy, | Characterization of dipyridamole as a novel ferroptosis inhibitor and its therapeutic potential in acute respiratory distress syndrome management |
| - | in-vivo, | Nor, | NA |
| 4989- | Dipy, | Dipyridamole |
| - | Review, | NA, | NA |
| 4987- | Dipy, | ATV, | Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination |
| - | in-vivo, | Nor, | NA |
| 4983- | Dipy, | ATV, | Targeting tumor cell metabolism via the mevalonate pathway: Two hits are better than one |
| - | Review, | Var, | NA |
| 6732- | Dipy, | Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway |
| - | in-vivo, | Nor, | NA |
| 6729- | Dipy, | Dipyridamole prevents triple-negative breast-cancer progression |
| - | Trial, | BC, | MDA-MB-231 |
| 6730- | Dipy, | ASA, | Dipyridamole enhances the anti-cancer ability of aspirin against colorectal cancer by inducing apoptosis in an unfolded protein response-dependent manner |
| - | vitro+vivo, | CRC, | NA |
| 6731- | Dipy, | Dipyridamole, an underestimated vascular protective drug |
| - | Review, | Nor, | NA |
| 6733- | Dipy, | Dipyridamole reverses peripheral ischemia and induces angiogenesis in the Db/Db diabetic mouse hind-limb model by decreasing oxidative stress |
| - | in-vivo, | Diabetic, | NA |
| 6734- | Dipy, | Cisplatin, | Adenosine enhances cisplatin sensitivity in human ovarian cancer cells |
| - | in-vitro, | Ovarian, | NA |
| 6735- | Dipy, | Dipyridamole Reverses Peripheral Ischemia and Induces Angiogenesis in the Db/Db Diabetic Mouse Hind Limb Model by Decreasing Oxidative Stress |
| - | in-vivo, | Nor, | NA |
| 6736- | Dipy, | Nucleoside Transport Inhibition by Dipyridamole Prevents Angiogenesis Impairment by Homocysteine and Adenosine |
| 6737- | Dipy, | Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 (TOLD) |
| - | Trial, | Nor, | NA |
| 6278- | DL, | Safety evaluation and risk assessment of d-Limonene |
| - | Review, | Nor, | NA |
| 6289- | DL, | D-Limonene modulates inflammation, oxidative stress and Ras-ERK pathway to inhibit murine skin tumorigenesis |
| - | in-vivo, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid